Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules

Journal of Microbiology, Immunology and Infection

Volumn 51, Issue 2, 2018, Pages 199-206

  Lee, Hong Yi ^a   Hsieh, Yu Chia ^a,b   Liu, Ching Chuan ^c   Huang, Yi Chuan ^b   Chang, Kuang Yi ^d,e   Chi, Hsin ^f   Chang, Luan Yin ^g   Huang, Yhu Chering ^a,b   Huang, Li Min ^g  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

13 Valent conjugate pneumococcal vaccine; Invasive pneumococcal pneumonia; Vaccine schedule

Indexed keywords

PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; VACCINE;

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; ONSET AGE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TAIWAN; VACCINATION; VACCINE FAILURE; COMMUNITY ACQUIRED INFECTION; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; PROCEDURES; VIROLOGY;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; TAIWAN; VACCINATION; VACCINES, CONJUGATE;

EID: 85030703993     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2017.08.022     Document Type: Article

References (32)

1. Verma, R., Khanna, P., Pneumococcal conjugate vaccine: a newer vaccine available in India. Hum Vaccin Immunother 8 (2012), 1317–1320.
2. Bartlett, J.G., Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis(52 Suppl 4), 2011, S296–S304.
3. Klugman, K.P., Madhi, S.A., Huebner, R.E., Kohberger, R., Mbelle, N., Pierce, N., A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 (2003), 1341–1348.
4. Madhi, S.A., Klugman, K.P., A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10 (2004), 811–813.
5. Simonsen, L., Taylor, R.J., Schuck-Paim, C., Lustig, R., Haber, M., Klugman, K.P., Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. Lancet Respir Med 2 (2014), 387–394.
6. Angoulvant, F., Levy, C., Grimprel, E., Varon, E., Lorrot, M., Biscardi, S., et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis 58 (2014), 918–924.
7. Kuo, C.Y., Hwang, K.P., Hsieh, Y.C., Cheng, C.H., Huang, F.L., Shen, Y.H., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine 29 (2011), 5171–5177.
8. Hsieh, Y.C., Lin, P.Y., Chiu, C.H., Huang, Y.C., Chang, K.Y., Liao, C.H., et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 27 (2009), 5513–5518.
9. Dagan, R., Givon-Lavi, N., Zamir, O., Sikuler-Cohen, M., Guy, L., Janco, J., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185 (2002), 927–936.
10. Huang, S.S., Hinrichsen, V.L., Stevenson, A.E., Rifas-Shiman, S.L., Kleinman, K., Pelton, S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124 (2009), e1–11.
11. Chen, C.J., Lin, P.Y., Tsai, M.H., Huang, C.G., Tsao, K.C., Wong, K.S., et al. Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan. Pediatr Infect Dis J 31 (2012), e196–201.
12. Hsieh, Y.C., Wang, C.W., Lai, S.H., Lai, J.Y., Wong, K.S., Huang, Y.C., et al. Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan. Pediatr Infect Dis J 30 (2011), 740–744.
13. Lin, T.Y., Hwang, K.P., Liu, C.C., Tang, R.B., Lin, C.Y., Gilbert, G.L., et al. Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age. Pediatr Infect Dis J 32 (2013), 419–421.
14. Wei, S.H., Chiang, C.S., Chiu, C.H., Chou, P., Lin, T.Y., Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 34 (2015), e71–e77.
15. Taiwan Centers for Disease Control, Pneumococcal conjugate vaccination program for children. April 24, 2016 Available at: http://www.cdc.gov.tw/professional/info.aspx?treeid=5b0231beb94edffc+&nowtreeid=EEA688E5F6508C27&tid=6496772897956EDC Accessed August 10, 2017.
16. Su, W.J., Lo, H.Y., Chang, C.H., Chang, L.Y., Chiu, C.H., Lee, P.I., et al. Effectiveness of pneumococcal conjugate vaccines of different valences against invasive pneumococcal disease among children in Taiwan: a nationwide study. Pediatr Infect Dis J 35 (2016), e124–e133.
17. Bartlett, J.G., Breiman, R.F., Mandell, L.A., File, T.M. Jr., Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 26 (1998), 811–838.
18. Hsieh, Y.C., Chi, H., Chang, K.Y., Lai, S.H., Mu, J.J., Wong, K.S., et al. Increase in fitness of Streptococcus pneumoniae is associated with the severity of necrotizing pneumonia. Pediatr Infect Dis J 34 (2015), 499–505.
19. Azzari, C., Moriondo, M., Indolfi, G., Cortimiglia, M., Canessa, C., Becciolini, L., et al. Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One, 5, 2010, e9282.
20. Park, S.Y., Van Beneden, C.A., Pilishvili, T., Martin, M., Facklam, R.R., Whitney, C.G., Invasive pneumococcal infections among vaccinated children in the United States. J Pediatr 156 (2010), 478–483.e2.
21. Ladhani, S.N., Slack, M.P., Andrews, N.J., Waight, P.A., Borrow, R., Miller, E., Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis 19 (2013), 61–68.
22. Snape, M.D., Klinger, C.L., Daniels, E.D., John, T.M., Layton, H., Rollinson, L., et al. Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial. Pediatr Infect Dis J 29 (2010), e80–90.
23. Dagan, R., Patterson, S., Juergens, C., Greenberg, D., Givon-Lavi, N., Porat, N., et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis 57 (2013), 952–962.
24. Moraga-Llop, F., Garcia-Garcia, J.J., Diaz-Conradi, A., Ciruela, P., Martínez-Osorio, J., González-Peris, S., et al. Vaccine failures in patients properly vaccinated with 13-valent pneumococcal conjugate vaccine in Catalonia, a region with low vaccination coverage. Pediatr Infect Dis J 35 (2016), 460–463.
25. Kaplan, S.L., Barson, W.J., Lin, P.L., Romero, J.R., Bradley, J.S., Tan, T.Q., et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 32 (2013), 203–207.
26. Moore, M.R., Link-Gelles, R., Schaffner, W., Lynfield, R., Holtzman, C., Harrison, L.H., et al. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. Lancet Respir Med 4 (2016), 399–406.
27. Andrews, N.J., Waight, P.A., Burbidge, P., Pearce, E., Roalfe, L., Zancolli, M., et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis 14 (2014), 839–846.
28. Hsieh, Y.C., Lin, T.L., Chang, K.Y., Huang, Y.C., Chen, C.J., Lin, T.Y., et al. Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as compared to its ancestral clone, Taiwan19F-14 (ST236). J Infect Dis 208 (2013), 203–210.
29. Lai, C.Y., Huang, L.M., Lee, P.Y., Lu, C.Y., Shao, P.L., Chang, L.Y., Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease. J Microbiol Immunol Infect 47 (2014), 23–27.
30. Chen, Y.J., Hsieh, Y.C., Huang, Y.C., Chiu, C.H., Clinical manifestations and microbiology of acute otitis media with spontaneous otorrhea in children. J Microbiol Immunol Infect 46 (2013), 382–388.
31. Ramsay, M.E., McVernon, J., Andrews, N.J., Heath, P.T., Slack, M.P., Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 188 (2003), 481–485.
32. Southern, J., McVernon, J., Gelb, D., Andrews, N., Morris, R., Crowley-Luke, A., et al. Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy. Clin Vaccine Immunol 14 (2007), 1328–1333.